Medical Radiology and Radiation Safety. 2026. Vol. 71. № 1

DOI:10.33266/1024-6177-2026-71-1-39-41

Yu.A. Kaidash1, E.L.Shaidiyarova 1, I.A. Baryshnikov1, P.V. Sychev1,
E.V. Mayakova1, A.V. Belostotsky1, Yu.D. Udalov 2

First Experience in Treatment of Papillary Thyroid Cancer
with Metastatic Lung Infection in a 12-year-old Patient (Clinical Case)

1 Federal Scientific Clinical Center for Medical Radiology and Oncology, Dimitrovgrad, Russia

2 A.I. Burnazyan Federal Medical Biophysical Center, Moscow, Russia

Contact person: Yulia Aleksandrovna Kaidash, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

ABSTRACT

Purpose: To demonstrate the successful experience of using systemic radioiodine therapy in the treatment of thyroid cancer in children.

Material and methods: In the FSBI FSCCRO of FMBA of Russia, as part of the implementation of the State assignment of FMBA of Russia, the development of a modern tool for epidemiological analysis of the results of the use of 131I radionuclide therapy in the treatment of thyroid cancer in the system of FMBA of Russia is carried out. Over 2.5 years of studies, data on the carrying out of radioiodine therapy for thyroid cancer in the nuclear medicine centers of the FMBA institutions of Russia have been studied on more than 1500 patients from different parts of the Russian Federation. The necessary medical documentation and clinical and anamnestic data of patients who underwent radioiodine therapy have been studied, and information has been collected and analyzed epidemiologically, and entered into an electronic database of patients of different age groups. However, in our database clinical cases of children’s treatment are quite rare.

Results: Due to the lack of an evidence based on prospective and retrospective studies with a large sample of pediatric patients, a significant portion of the treatment concepts for differentiated thyroid cancer in children are derived from the experience of treating adult patients. However, the more aggressive course of the disease in children, coupled with a good overall prognosis and a long life expectancy, during which adverse effects of radioiodine therapy may occur, requires a personalized approach, as demonstrated in our clinical case.

Conclusion: Based on the above, it is evident that it is necessary to develop special recommendations for the treatment and monitoring of pediatric patients with thyroid neoplasms.

Keywords: thyroid cancer, childhood, radioiodine therapy, 131I

For citation: Kaidash YuA, Shaidiyarova EL, Baryshnikov IA, Sychev PV, Mayakova EV, Belostotsky AV, Udalov YuD. The first experience of papillary thyroid cancer treatment with metastatic lung lesions in a 12-year-old patient (Clinical Case). Medical Radiology and Radiation Safety. 2026;71(1):39–41. (In Russian). DOI:10.33266/1024-6177-2026-71-1-39-41

 

References

1. Differentsirovannyy Rak Shchitovidnoy Zhelezy = Differentiated Thyroid Cancer. Clinical Guidelines. Moscow, Ministry of Health of the Russian Federation Publ., 2020. 56 p. (In Russ.).

2. Durnov L.A., Goldobenko G.V. Detskaya Onkologiya = Pediatric Oncology. Textbook. Moscow, Meditsina Publ., 2002. 607 p. (In Russ.).

3. Paches A.I. Opukholi Golovy i Shei = Head and Neck Tumors. Clinical Guidelines. Moscow, Prakticheskaya Meditsina Publ., 2013. P. 454-473 (In Russ.).

4. Detskaya Onkologiya = Pediatric Oncology. National Guidelines. Ed. Aliyev M.D., Polyakov V.G., Mentkevich G.L., Mayakova S.A. Moscow, Prakticheskaya Meditsina Publ., 2012. 684 (In Russ.).

5. Rumyantsev P.O., Il’in A.A., Rumyantseva U.V., Sayenko V.A. Rak Shchitovidnoy Zhelezy. Sovremennyye Podkhody k Diagnostike i Lecheniyu = Thyroid Cancer. Modern Approaches to Diagnostics and Treatment. Moscow, GEOTAR-Media Publ., 2009. 448 p. (In Russ.).

6. Cooper D.S., Doherty G.M., Haugen B.R., Kloos R.T., Lee S.L., Mandel S.J., Mazzaferri E.L., McIver B., Sherman S.I., Tuttle R.M. American Thyroid Association Guidelines Taskforce: Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2006 Feb;16;2:109-42. Doi: 10.1089/thy.2006.16.109. PMID: 16420177.

7. Mhiri A., Elbez I., Slim I., Ben Slimène M.F. Differentiated Thyroid Cancer in Children: The Contribution of Radioiodine Therapy. Thyroid Disorders Ther. 2015;4:171. Doi: 10.4172/2167-7948.1000171.

8. Sychev P.V., Udalov Yu.D., Mayakova Ye.V., Shcherbakov M.I., Kaydash Yu.A., Kadyrova A.M. RADIOR-25. Certificate of State Registration of the Database No. 2024625254 Russian Federation. No. 2024625013. Declared 07.11.2024. Published 18.11.2024. Applicant FNKTsRIO FMBA of Russia (In Russ.). 

 

 

 PDF (RUS) Full-text article (in Russian)

 

Conflict of interest. The authors declare no conflict of interest.

Financing. The work was performed within the framework of the state assignment of the FMBA of Russia registration number R&D 1022060300090-7-3.2.21.

Contribution. Article was prepared with equal participation of the authors.

Article received: 20.11.2025. Accepted for publication: 25.12.2025.